These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28389391)

  • 21. Real-life experience in the treatment of solar urticaria: retrospective cohort study.
    Snast I; Lapidoth M; Uvaidov V; Enk CD; Mazor S; Hodak E; Levi A
    Clin Exp Dermatol; 2019 Jul; 44(5):e164-e170. PubMed ID: 30828851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A critical appraisal of omalizumab as a therapeutic option for chronic refractory urticaria/angioedema.
    Lang DM
    Ann Allergy Asthma Immunol; 2014 Apr; 112(4):276-9. PubMed ID: 24589165
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful treatment of symptomatic dermographism in an adolescent with omalizumab.
    Kaya Erdogan H; Ağaoğlu E; Acer E; Batan T; Saracoglu ZN
    Dermatol Ther; 2020 Nov; 33(6):e14304. PubMed ID: 32926517
    [No Abstract]   [Full Text] [Related]  

  • 24. Omalizumab as Third-Line Therapy for Urticaria During Pregnancy.
    Ensina LF; Cusato-Ensina AP; Camelo-Nunes IC; Solé D
    J Investig Allergol Clin Immunol; 2017; 27(5):326-327. PubMed ID: 29057743
    [No Abstract]   [Full Text] [Related]  

  • 25. Omalizumab as a treatment option for antihistamine-refractory aquagenic urticaria.
    Kaur S; Jabbal IS; Bhasin AK
    BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35850790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case of postural urticaria in a 14-year-old girl.
    Gabrielli S; Le M; Netchiporouk E; Ben-Shoshan M
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34711626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of omalizumab in severe solar urticaria.
    de Dios-Velázquez Á; González-de Arriba M; Beteta-Gorriti V; Macías E; Campanón-Toro V; Dávila I
    Ann Allergy Asthma Immunol; 2016 Mar; 116(3):260-2. PubMed ID: 26803538
    [No Abstract]   [Full Text] [Related]  

  • 28. Urticaria control test might misevaluate disease control in particular patients treated with omalizumab.
    Türk M; Yılmaz İ
    Ann Allergy Asthma Immunol; 2019 Mar; 122(3):342-343. PubMed ID: 30529015
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of omalizumab in the treatment of chronic urticaria.
    Cordeiro Moreira AS; Rosmaninho Lopes de Soares E Silva MI; Pereira Guilherme MA; da Silva Ferreira JA; Fonseca Moreira da Silva JP
    Eur Ann Allergy Clin Immunol; 2016 Nov; 48(6):242-246. PubMed ID: 27852430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience.
    Nettis E; Cegolon L; Di Leo E; Canonica WG; Detoraki A;
    Ann Allergy Asthma Immunol; 2018 Mar; 120(3):318-323. PubMed ID: 29508719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of Antihistamines During Omalizumab Therapy in Chronic Urticaria in the Routine Clinical Practice. A 48-Patient Observational Trial.
    Menéndez-Sánchez M; Pérez-Fernández E; López-Estebaranz JL; Gómez-de la Fuente E
    Actas Dermosifiliogr; 2024 Jun; 115(6):636-638. PubMed ID: 38382744
    [No Abstract]   [Full Text] [Related]  

  • 32. Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria.
    Kaplan A; Ferrer M; Bernstein JA; Antonova E; Trzaskoma B; Raimundo K; Rosén K; Omachi TA; Khalil S; Zazzali JL
    J Allergy Clin Immunol; 2016 Feb; 137(2):474-81. PubMed ID: 26483177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic Idiopathic Urticaria.
    Wu EY; Saini SS
    J Allergy Clin Immunol Pract; 2015; 3(6):1003-4; quiz 105. PubMed ID: 26553623
    [No Abstract]   [Full Text] [Related]  

  • 34. Solar urticaria treated with omalizumab.
    Schaffenburg WC; Guerrero KT; Marks SN
    Cutis; 2019 Jul; 104(1):E4-E5. PubMed ID: 31487346
    [No Abstract]   [Full Text] [Related]  

  • 35. Solar urticaria induced by visible light: successful treatment with omalizumab.
    Terrani I; Bircher AJ; Scherer Hofmeier K
    Clin Exp Dermatol; 2016 Dec; 41(8):890-892. PubMed ID: 27766671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term omalizumab therapy for refractory chronic spontaneous urticaria: a real-life experience.
    Ensina LF; de Lacerda AE; Machado LM; Camelo-Nunes I; Solé D
    Ann Allergy Asthma Immunol; 2015 Dec; 115(6):536. PubMed ID: 26653279
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical management of urticaria using omalizumab: the first licensed biological therapy available for chronic spontaneous urticaria.
    Giménez-Arnau AM; Toubi E; Marsland AM; Maurer M
    J Eur Acad Dermatol Venereol; 2016 Jul; 30 Suppl 5():25-32. PubMed ID: 27286500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum IgE as an immunological marker to predict response to omalizumab treatment in symptomatic chronic urticaria.
    Straesser MD; Oliver E; Palacios T; Kyin T; Patrie J; Borish L; Saini SS; Lawrence MG
    J Allergy Clin Immunol Pract; 2018; 6(4):1386-1388.e1. PubMed ID: 29175369
    [No Abstract]   [Full Text] [Related]  

  • 39. Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials.
    Zhao ZT; Ji CM; Yu WJ; Meng L; Hawro T; Wei JF; Maurer M
    J Allergy Clin Immunol; 2016 Jun; 137(6):1742-1750.e4. PubMed ID: 27040372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of occupational delayed pressure urticaria and angioedema with omalizumab.
    Geller M
    Ann Allergy Asthma Immunol; 2016 Jan; 116(1):81-2. PubMed ID: 26602491
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.